FDA Inspection 740444 — Akrimax Pharmaceuticals, LLC

Akrimax Pharmaceuticals, LLC — FEI 3007295270

The FDA completed an inspection of Akrimax Pharmaceuticals, LLC on Aug 19, 2011 in Cranford, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 19, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cranford, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.